Xinpei Wang

5PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 30, 2026
Targeting PKMYT1 enhances antitumor immune responses to PD-L1 blockade in castration-resistant prostate cancer.

Lin Gao, Baozhen Wang, Hui Liu

|Jan 30, 2026
FOSL2 Regulates PD-L1 and Modulates Hormone Therapy Response Heterogeneity.

Feifei Sun, Baozhen Wang, Shuyu Mei

|Nov 26, 2022
IDH Mutations Are Potentially the Intrinsic Genetic Link among the Multiple Neoplastic Lesions in Ollier Disease and Maffucci Syndrome: A Clinicopathologic Analysis from a Single Institute in Shanghai, China.

Chunyan Chen, Jian Li, Ting Jiang

|Jun 10, 2022
Long-Term Exposure to Decabromodiphenyl Ether Promotes the Proliferation and Tumourigenesis of Papillary Thyroid Carcinoma by Inhibiting TRß.

Xinpei Wang, Xiujie Cui, Qian Zhao

|May 04, 2022
RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway.

Feifei Sun, Xinpei Wang, Jing Hu

Pageof 1

Frequent Collaborators

3 joint publications

Feifei Sun

3 joint publications

Lin Gao

3 joint publications

Bo Han

2 joint publications

Wenyao Liu